Quarterly results round-up: no change to Cyberonics outlook in spite of recall, Lombard grows revenues
This article was originally published in Clinica
Executive Summary
Vagal nerve stimulation (VNS) specialist Cyberonics has reported top-line growth during its first fiscal quarter of 2012, but saw profits hit by a one-off charge related to the withdrawal of its Aspire generators from the market.